Executive Insights for Life Sciences Innovators – Détails, épisodes et analyse

Détails du podcast

Informations techniques et générales issues du flux RSS du podcast.

Executive Insights for Life Sciences Innovators

GeneCoda® Executive Search

Sciences

Fréquence : 1 épisode/14j. Total Éps: 28

Executive Insights features conversations with visionary leaders shaping the future of biotech, pharma, medtech, diagnostics, and tools. Hear from CEOs, entrepreneurs, and investors about building companies, raising capital, and driving innovation. Whether you are growing a startup or scaling a global life sciences business, these candid discussions deliver the insights you need to succeed.

Lire plusRéduire

Site

RSS

Apple

Données mises à jour le 14/10/2026

Classements récents

Dernières positions dans les classements Apple Podcasts et Spotify.

Apple Podcasts

🇺🇸 États-Unis - Life Sciences
14/10/2026
#100

Spotify

Aucun classement récent disponible

Liens partagés entre épisodes et podcasts

Liens présents dans les descriptions d'épisodes et autres podcasts les utilisant également.

https://www.genecoda.com/hire-life-sciences-executives/executive-insights-for-life-sciences-innovators-podcast/
28 partages

Qualité et score du flux RSS

Évaluation technique de la qualité et de la structure du flux RSS.

Qualité du flux RSS

À améliorer

Score global : 32%

Historique des publications

Répartition mensuelle des publications d'épisodes au fil des années.

Year

Derniers épisodes publiés

Liste des épisodes récents, avec titres, durées et descriptions.

Mark Rutledge | World Precision Instruments - Advancing Preclinical Research Through Better Tools and Models

mercredi 30 septembre 2026 • Durée 26:30

In this episode of Executive Insights for Life Sciences Innovators, Don Alexander speaks with Mark Rutledge, President and CEO of World Precision Instruments.

Mark discusses how evolving research needs are reshaping the tools and technologies used in preclinical science. The conversation explores the growing importance of more standardized and physiologically relevant in vitro models, including organ-on-chip applications, as researchers look for better ways to generate meaningful data earlier in development.

Mark also shares perspective from his leadership experience across diagnostics, life sciences tools, and commercial organizations. He discusses how World Precision Instruments evaluates where to innovate, the role of customer insight in product development, and the challenges of leading an established scientific instrumentation company through changing research and market expectations.

This episode was streamed live on YouTube on September 28, 2026. Learn more at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠genecoda.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

Lire plusRéduire

Justin Byers | Axio BioPharma - Building the Data Foundation for AI-Ready Biomanufacturing

mardi 15 septembre 2026 • Durée 26:36

In this episode of Executive Insights for Life Sciences Innovators, Don Alexander speaks with Justin Byers, Founder and CEO of Axio BioPharma.

Justin discusses why the next generation of AI-enabled biomanufacturing depends on something more fundamental than better algorithms: better access to structured, contextualized process data. The conversation explores how fragmented information across labs, manufacturing sites, sponsors, and external partners can slow development, complicate tech transfer, and limit the value organizations can extract from AI.

Justin also shares perspective from his career across analytical science, process development, commercialization, and company building. He discusses Axio BioPharma’s approach to connecting real-world laboratory execution with broader process knowledge, the challenges of transferring knowledge across organizational boundaries, and what life sciences leaders should consider as they prepare their manufacturing operations for more effective use of AI.

This episode was streamed live on YouTube on September 14, 2026. Learn more at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠genecoda.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

Lire plusRéduire

Dhruv Patwardhan | LuminOne - Accountable AI for Life Sciences Commercial Teams

samedi 29 août 2026 • Durée 32:16

In this episode of Executive Insights for Life Sciences Innovators, Don Alexander speaks with Dhruv Patwardhan, Founder of LuminOne.

Dhruv discusses how AI can improve commercial decision-making in life sciences by helping teams make better use of fragmented market, account, and customer signals. The conversation explores where AI is genuinely useful today, why many implementations stall after the pilot stage, and how leaders can distinguish practical workflow improvements from impressive demonstrations that fail to change day-to-day execution.

Dhruv also shares perspective from more than a decade in life sciences commercial leadership, including lessons on workflow design, source traceability, human oversight, and accountability. He explains why AI should support rather than replace human judgment, and what CEOs and commercial leaders should consider as AI becomes more deeply embedded in commercial organizations.

This episode was streamed live on YouTube on August 28, 2026. Learn more at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠genecoda.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

Lire plusRéduire

Pawel Krysiak | Jaya Biosciences - Gene Therapy for Neurodegeneration

mardi 30 juin 2026 • Durée 34:33

In this episode of Executive Insights for Life Sciences Innovators, Don Alexander speaks with Pawel Krysiak, President & CEO of Jaya Biosciences.

Pawel discusses JayaBio’s work to develop CNS-directed gene therapies for genetically defined neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and frontotemporal dementia. The conversation explores JayaBio’s focus on lysosomal enzyme gene heterozygosity and how this approach may help identify patient subpopulations within diseases historically treated as broad, heterogeneous conditions.

Pawel also shares perspective from more than 20 years across neurodegeneration, oncology, rare diseases, commercialization, market access, and company building, including lessons from orphan drug launches and the challenge of advancing differentiated science toward clinical development.

This episode was streamed live on YouTube on June 29, 2026. Learn more at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠genecoda.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

Lire plusRéduire

David Pass | AltrixBio - Gut-Targeted Oral Therapy for Diabetes and Obesity

mardi 16 juin 2026 • Durée 21:25

In this episode of Executive Insights for Life Sciences Innovators, Don Alexander speaks with David Pass, CEO and President of AltrixBio.

David discusses AltrixBio’s work to advance AJN003, a once-daily, oral, gut-targeted therapeutic candidate being developed for type 2 diabetes, obesity, and related cardiometabolic conditions. The conversation explores how AltrixBio’s approach is inspired by the metabolic effects observed after bariatric surgery, and how a non-systemic oral therapy could address important gaps in today’s treatment landscape.

David also shares perspective from more than 25 years across diabetes, obesity, cardiovascular disease, pharma, biotech, and digital health, including lessons from commercial leadership, company building, and advancing differentiated science toward the clinic.

This episode was streamed live on YouTube on June 15, 2026. Learn more at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠genecoda.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

Lire plusRéduire

Dave Gallup | EMPIRI - Functional Precision Oncology and Live Tumor Tissue Drug Response

samedi 30 mai 2026 • Durée 29:30

In this episode of Executive Insights for Life Sciences Innovators, Don Alexander speaks with Dave Gallup, Co-Founder and CEO of EMPIRI, an oncology platform company advancing functional precision oncology through its E-slice platform.

Dave discusses how EMPIRI is using live human tumor tissue to measure drug response while preserving native tumor architecture and the tumor microenvironment. The conversation explores how E-slice may complement genomic and molecular profiling, help bridge the translational gap between preclinical models and clinical outcomes, and support better decision-making in oncology drug development.

Dave also shares his path from building biological analysis businesses to co-founding EMPIRI, including lessons from scaling complex technical platforms, earning market trust, and balancing scientific rigor with commercial execution.

This episode covers functional precision oncology, live tumor tissue assays, oncology drug development, translational science, and the future role of empirical drug response data in cancer research and care.

This episode was streamed live on YouTube on May 29, 2026. Learn more at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠genecoda.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

Lire plusRéduire

Anil Goyal | IMMvention Therapeutix - Collaborations & Building Biotech Innovation Ecosystems

mardi 19 mai 2026 • Durée 33:18

In this episode of Executive Insights for Life Sciences Innovators, Don Alexander speaks with Dr. Anil Goyal, Co-Founder and CEO of IMMvention Therapeutix, a VC-backed biotechnology company developing globally accessible therapies for rare and chronic diseases, including sickle cell disease and Friedreich’s ataxia.

Anil shares insights from nearly 30 years in biotechnology leadership spanning company formation, fundraising, strategic partnerships, and therapeutic innovation across multiple modalities and disease areas. The conversation explores Immvention’s scientific approach, the realities of building emerging biotech companies in today’s funding environment, and the balance between scientific ambition and operational discipline.

They also discuss Immvention’s strategic collaboration with Novo Nordisk focused on developing oral therapies for sickle cell disease and other chronic diseases, including what partnerships like these can signal about platform validation and long-term development strategy.

Beyond his work in biotechnology, Anil is also a passionate ecosystem builder and co-founder of the OpenDoors Group, a nonprofit organization focused on increasing equity, diversity, and access for the next generation of life sciences entrepreneurs and innovators. The discussion also touches on North Carolina’s growing R&D ecosystem and the importance of regional innovation clusters in advancing life sciences.

This episode was streamed live on YouTube on May 18, 2026. Learn more at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠genecoda.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

Lire plusRéduire

Stan Watowich | Ridgeline Therapeutics - Targeting Aging Biology and Chronic Disease

samedi 2 mai 2026 • Durée 32:21

In this episode of Executive Insights for Life Sciences Innovators, Don Alexander speaks with Stan Watowich, Founder and CEO of Ridgeline Therapeutics and Professor of Biochemistry and Molecular Biology at the University of Texas Medical Branch.

Stan shares his journey from academic science to biotech company building, and how Ridgeline is developing small molecule therapies aimed at improving how we age and treat chronic disease. The conversation explores the company’s focus on NNMT, a key regulator of cellular energetics, and the broader opportunity to address age-linked conditions through targeted drug discovery.

They also discuss the realities of translating academic research into commercial success, prioritizing programs in a constrained funding environment, and what it takes to build a company around high-conviction science.

This episode was streamed live on YouTube on May 1, 2026. Learn more at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠genecoda.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

Lire plusRéduire

Michael Heltzen | eXoZymes – AI-Enabled Cell-Free Biomanufacturing and the Future of Enzyme Engineering

samedi 18 avril 2026 • Durée 43:23

In this episode of Executive Insights for Life Sciences Innovators, we speak with Michael Heltzen, CEO of eXoZymes, a publicly traded biotechnology company developing AI-enabled, cell-free biomanufacturing platforms designed to expand what is possible with enzyme engineering.

Michael discusses the company’s thesis that producing complex molecules outside living cells may allow greater control, scalability, and speed compared to traditional biologic manufacturing approaches.

We explore how advances in artificial intelligence are helping identify and optimize enzyme pathways, the strategic considerations involved in building a platform company in today’s capital environment, and what differentiates cell-free systems from more established synthetic biology approaches.

We also discuss the realities of scaling a publicly traded life sciences company, how leaders balance scientific ambition with commercial discipline, and where cell-free biomanufacturing could create meaningful impact across nutraceutical, pharmaceutical, and industrial markets.This episode was streamed live on YouTube on April 17, 2026. Learn more at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠genecoda.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

Lire plusRéduire

Charles Legg | CureLab Oncology – Advancing Immuno-Oncology Through Targeting the Tumor Microenvironment

mardi 7 avril 2026 • Durée 30:27

In this episode of Executive Insights for Life Sciences Innovators, we speak with Charles Legg of CureLab Oncology, a biotechnology company developing novel immuno-oncology therapies designed to more precisely modulate immune pathways within the tumor microenvironment.

Charles shares his perspective on how immunotherapy continues to evolve beyond first-generation checkpoint inhibitors and why a deeper understanding of tumor biology may lead to more durable and broadly effective cancer treatments. We discuss the scientific rationale behind targeting immune signaling pathways, the challenges of translating complex biology into therapeutic development programs, and how emerging platform approaches may shape the future of oncology innovation.

We also explore the realities of building oncology companies in today’s capital environment, including capital efficiency, prioritization of development milestones, and how biotechnology leaders communicate complex scientific strategies to investors and partners.

This episode was streamed live on YouTube on April 6 2026. Learn more at ⁠⁠⁠⁠⁠⁠⁠genecoda.com⁠⁠⁠⁠⁠⁠⁠.

Lire plusRéduire

Podcasts Similaires Basées sur le Contenu

Découvrez des podcasts liées à Executive Insights for Life Sciences Innovators. Explorez des podcasts avec des thèmes, sujets, et formats similaires. Ces similarités sont calculées grâce à des données tangibles, pas d'extrapolations !

Il n'y a pas de contenu associé à ce podcast.

À propos Méthodologie Contact Me soutenir Politique de confidentialité Mentions légales

Executive Insights for Life Sciences Innovators – Détails, épisodes et analyse

Détails du podcast

Classements récents

Apple Podcasts

Spotify

Liens partagés entre épisodes et podcasts

Other1

Qualité et score du flux RSS

Historique des publications

Derniers épisodes publiés

Podcasts et contenus similaires

Podcasts Similaires Basées sur le Contenu

Apple Podcasts

Spotify

Podcasts Similaires Basées sur le Contenu

Other1